PharmacyCodes



Gliclazidum [INN-Latin] en es it fr

Gliclazidum [INN-Latin] Brand names, Gliclazidum [INN-Latin] Analogs

Gliclazidum [INN-Latin] Brand Names Mixture

  • No information avaliable

Gliclazidum [INN-Latin] Chemical_Formula

C15H21N3O3S

Gliclazidum [INN-Latin] RX_link

No information avaliable

Gliclazidum [INN-Latin] fda sheet

Gliclazidum [INN-Latin] msds (material safety sheet)

Gliclazidum_[INN-Latin] MSDS

Gliclazidum [INN-Latin] Synthesis Reference

No information avaliable

Gliclazidum [INN-Latin] Molecular Weight

323.412 g/mol

Gliclazidum [INN-Latin] Melting Point

181 oC

Gliclazidum [INN-Latin] H2O Solubility

No information avaliable

Gliclazidum [INN-Latin] State

Solid

Gliclazidum [INN-Latin] LogP

2.418

Gliclazidum [INN-Latin] Dosage Forms

Tablet

Gliclazidum [INN-Latin] Indication

For the treatment of Diabetes mellitus

Gliclazidum [INN-Latin] Pharmacology

Gliclazide is a second generation sulphonylurea which acts as a hypoglycemic agent. It stimulates beta cells of the islet of Langerhans in the pancreas to release insulin. It also enhances peripheral insulin sensitivity. Overall it potentiates insulin release and improves insulin dynamics.

Gliclazidum [INN-Latin] Absorption

Rapidly and well absorbed but may have wide inter- and intra-individual variability.

Gliclazidum [INN-Latin] side effects and Toxicity

LD50=3000 mg/kg (orally in mice)

Gliclazidum [INN-Latin] Patient Information

No information avaliable

Gliclazidum [INN-Latin] Organisms Affected

Humans and other mammals